What is the current Price Target for the Aeglea BioTherapeutics Inc stock?

The average Aeglea BioTherapeutics Inc target price is $56.63. This is 265.56% higher than the current stock price. The highest price target is 358.36%, the lowest is 74.31%. 8 Analysts have issued a price target Aeglea BioTherapeutics Inc 2026 .

How high will the Aeglea BioTherapeutics Inc stock rise?

No reliable answer can be given as to how high the Aeglea BioTherapeutics Inc stock will rise. The performance of stocks, including the Aeglea BioTherapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aeglea BioTherapeutics Inc stock today?

The performance of Aeglea BioTherapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aeglea BioTherapeutics Inc stock fall?

The decline in Aeglea BioTherapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aeglea BioTherapeutics Inc Forecast, price target & analysts

$15.49

1.27% today

Nasdaq, Apr 02, 10:00 pm CET

ISIN

US00773J1034

Symbol

SYRE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Aeglea BioTherapeutics Inc Target price 2025 - Analyst rating & recommendation

Aeglea BioTherapeutics Inc Classifications & Recommendation:

Buy

90%

Hold

10%

Aeglea BioTherapeutics Inc Price Target

Target Price	$56.63
Price	$15.49
Potential	265.56% register free of charge
Number of Estimates	8

	8 Analysts have issued a price target Aeglea BioTherapeutics Inc 2026 . The average Aeglea BioTherapeutics Inc target price is $56.63. This is 265.56% register free of charge higher than the current stock price. The highest price target is $71.00 358.36% register free of charge , the lowest is $27.00 74.31% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend Aeglea BioTherapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aeglea BioTherapeutics Inc stock has an average upside potential 2026 of 265.56% register free of charge . Most analysts recommend the Aeglea BioTherapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.18	-3.46
	76.89%	8.81%
P/E		negative

10 Analysts have issued a Aeglea BioTherapeutics Inc forecast for earnings per share. The average Aeglea BioTherapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.18	76.89%
2025	$-3.46 8.81% Unlock
2026	$-3.66 5.78% Unlock
2027	$-3.70 1.09% Unlock
2028	$-4.41 19.19% Unlock
2029	$-4.34 1.59% Unlock

Current	-4.84	849.02%
2025	-4.43 8.47% Unlock
2026	-4.18 5.64% Unlock
2027	-4.13 1.20% Unlock
2028	-3.47 15.98% Unlock
2029	-3.52 1.44% Unlock

Aeglea BioTherapeutics Inc...

Current Aeglea BioTherapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Jones Trading	Locked ➜ Locked	Locked	Dec 11 2024
Baird	Locked ➜ Locked	Locked	Nov 13 2024
Guggenheim	Locked ➜ Locked	Locked	Oct 25 2024
Wedbush	Locked ➜ Locked	Locked	Sep 04 2024

Analyst Rating	Date
Locked Jones Trading: Locked ➜ Locked	Dec 11 2024
Locked Baird: Locked ➜ Locked	Nov 13 2024
Locked Guggenheim: Locked ➜ Locked	Oct 25 2024
Locked Wedbush: Locked ➜ Locked	Sep 04 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 73.49%

BioNTech SE - ADR 48.29%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now